A truvada hypersensitivity reaction simulating abacavir hypersensitivity [2]

AIDS

Volumn 21, Issue 16, 2007, Pages 2252-2253

  De Perio, Marie A ^a   Gomez, Francisco J ^a   Frame, Peter T ^a   Fichtenbaum, Carl J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HYPERTENSIVE FACTOR; INFUSION FLUID; LAMIVUDINE PLUS ZIDOVUDINE; PLACEBO; VIRUS RNA;

ADULT; AFRICAN AMERICAN; CASE REPORT; CONVALESCENCE; DRUG HYPERSENSITIVITY; FATIGUE; FEVER; HEADACHE; HEART RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; MALE; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; SKIN EXFOLIATION; SYSTOLIC BLOOD PRESSURE; VIRUS LOAD; VOMITING;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; DEOXYCYTIDINE; DRUG COMBINATIONS; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS;

EID: 37349041032     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f08b84     Document Type: Letter

References (6)

1. Symonds W, Cutrell A, Edwards M, Steel H, Spreen B, Powell G, et al. Risk factor analysis of hypersensitivity reactions to abacavir. Clin Ther 2002; 24:565-573.
2. Hetherington S, McGuirk S, Powell G, Cutrell A, Naderer O, Spreen B, et al. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 2001; 23:1603-1614.
3. Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002; 359:1121-1122.
4. Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, et al. Association between presence of HLA-BM5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse transcriptase inhibitor abacavir. Lancet 2002; 359:727-732.
5. Saag MS. Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus. Clin Infect Dis 2006; 42:126-131.
6. Lockhart S, Rathbun R, Stephens J, Baker DL, Drevets DA, Greenfield RA, et al. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases. AIDS 2007; 21:1370-1373.